Lawmakers seek a new vision for developing cures
By Mari Serebrov
Thursday, May 8, 2014
As technology outpaces the regulatory process and spending caps cut into federal investments in biomedical R&D, several lawmakers are asking the experts to put on their thinking caps to envision new ways to sponsor research and speed the development of promising new treatments and cures.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.